Migraine Prevention with Erenumab: Focus on Patient Selection, Perspectives and Outcomes

Overview of attention for article published in Therapeutics and Clinical Risk Management, April 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 25 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 5,360 followers.

☏ Migraine prevention with erenumab | TCRM - Dove Medical Press #News https://t.co/qmO6In7Dos

Reply Repost Favourite